Microsatellite analyses of recurrence or second primary tumor in head and neck cancer

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2771-2776

  Ronchetti, D ^a   Arisi, E ^a   Neri, A ^a   Pruneri, G ^b   Digiuni, B ^a   Sambataro, G ^a   Gallo, O ^c   Pignataro, Lorenzo ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Head and neck cancer; Microsatellite analyses; Recurrence; Second primary tumours

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HETEROZYGOSITY; HUMAN; MALE; MICROSATELLITE MARKER; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; GENOMIC INSTABILITY; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OROPHARYNGEAL NEOPLASMS;

EID: 22944491475     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Parkin DM, Laara E and Muir CS: Estimate of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41(2): 184-197, 1988.
2. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328(3): 184-194, 1993.
3. Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, Laramore GE, Marcial VA, Davis LW, Cox JD et al: Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 17(3): 449-556, 1989.
4. Licciardello JT, Spitz MR and Hong WK: Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 17(3): 467-476, 1989.
5. Jones AS, Morar P, Phillips DE, Field JK, Husband D and Helliwell TR: Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75(6): 1343-1353, 1995.
6. Gollin SM: Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23(3): 238-253, 2001.
7. Ishitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K and Yamamoto T: Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 59(4): 559-562, 1989.
8. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53(19): 4477-4480, 1993.
9. Califano J, Westra WH, Koch W, Meininger G, Reed A, Yip L, Boyle JO, Lonardo F and Sidransky D: Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Nat Cancer Inst 91(7): 599-604,1999.
10. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61(5): 759-777, 1990.
11. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F and Sidransky D: Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 91(21): 9871-9875, 1994.
12. Sidransky D: Nucleic acid-based methods for the detection of cancer. Science 278(5340): 1054-1059, 1997.
13. Matsuzoe D, Hideshima T, Ohshima K, Kawahara K, Shirakusa T and Kimura A: Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer 79(9-10): 1549-1552, 1999.
14. Huang J, Behrens C, Wistuba I, Gazdar AF and Jagirdar J: Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol 5(6): 321-329, 2001.
15. de la Chapelle A: Microsatellite instability. N Engl J Med 349(3): 209-210, 2003.
16. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM and Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1994.
17. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature 368: 753-756, 1994.
18. Dockhorn-Dworniczak B, Dworniczak B, Brommelkamp L, Bulles J, Horst J and Bocker WW: Non-isotopic detection of single strand conformation polymorphism (PCR-SSCP): a rapid and sensitive technique in diagnosis of phenylketonuria. Nucleic Acids Res 19(9): 2500, 1991.
19. Tang M, Pires Y, Schultz M, Duarte I, Gallegos M and Wistuba II: Microsatellite analysis of synchronous and metachronous tumors: a tool for double primary tumor and metastasis assessment. Diagn Mol Pathol 12(3): 151-159, 2003.
20. Sardi I, Franchi A, Ferriero G, Frittelli A, Bruschini L, Montali E and Gallo O: Prediction of recurrence by microsatellite analysis in head and neck cancer. Genes Chromosomes Cancer 29(3): 201-206, 2000.
21. Spafford MF, Koch WM, Reed AL, Califano JA, Xu LH, Eisenberger CF, Yip L, Leong PL, Wu L, Liu SX, Jeronimo C, Westra WH and Sidransky D: Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 7(3): 607-612, 2001.
22. Fiedler W, Hoppe C, Schimmel B, Koscielny S, Dahse R, Bereczki Z, Claussen U, Ernst G and von Eggeling F: Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Mol Med 9(4): 417-423, 2002.
23. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB and Brakenhoff RH: Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24(2): 198-206, 2002.
24. Scholes AG, Woolgar JA, Boyle MA, Brown JS, Vaughan ED. Hart CA, Jones AS and Field JK: Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 58(9): 2003-2006, 1998.
25. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow GB, Leemans CR and Braakhuis BJ: Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161(3): 1051-1060, 2002.
26. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W and Sidransky D: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56(11): 2488-2492, 1996.
27. Reid CB, Snow GB, Brakenhoff RH and Braakhuis BJ: Biologic implications of genetic changes in head and neck squamous cell carcinogenesis. Aust N Z J Surg 67(7): 410-416, 1997.
28. Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR and Braakhuis BJ: Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 7(6): 1523-1532, 2001.
29. Ha PK and Califano JA: The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14(5): 363-369, 2003.
30. Kramer FJ, Janssen M and Eckardt A: Second primary tumours in oropharyngeal squamous cell carcinoma. Clin Oral Investig 8(2): 56-62, 2004.
31. Lippmann SM and Hong WK: Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 17(3): 691-694, 1989.
32. Mashberg A: Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration. Oral Oncol 36(3): 253-255, 2000.
33. Weber JL, Kwitek AE and May PE: Dinucleotide repeat polymorphism at the D15S87 locus. Nucleic Acids Res 18(15): 4640, 1990.